This Week at FDA: Califf testimony, AI/ML tools for biologic characterization, and more
This Week at FDAMichael Mezher
Biologics/ biosimilars/ vaccinesMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/PolicyThis Week at FDAMichael MezherBiologics/ biosimilars/ vaccinesMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory Intelligence/Policy